{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-064716","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.951581+00:00","generated_at":"2026-06-01T09:17:26.338952+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Bicycle Therapeutics raises ~$555M in private placement of 25.9M ADSs at $21.42; cash runway into H2 2027","bullets":["Sold 25,933,706 ADSs (and non-voting ordinary shares in lieu) at $21.42/share for gross proceeds of ~$555M.","Closing expected May 28, 2024; proceeds will boost cash to ~$1.0B, extending runway into second half of 2027.","Offering conducted as private placement under Section 4(a)(2) and Rule 506 of Regulation D.","Company to file a resale registration statement within 30 calendar days after closing or 15 business days if Form S-3ASR is effective."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-064716","json":"https://secwatch.observer/filing/0001104659-24-064716.json","markdown":"https://secwatch.observer/filing/0001104659-24-064716.md","text":"https://secwatch.observer/filing/0001104659-24-064716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924064716/0001104659-24-064716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924064716/tm2415400d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:17:26.338952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}